O6 Analysis of angiogenic gene profiling after E-selectin + stem cell therapy in murine ischemic limb
نویسندگان
چکیده
Abstract Introduction There remains a paucity of novel therapeutics for limb salvage in patients with critical ischemia (CLI) whom revascularization procedures have failed and amputation is imminent. We shown that E-selectin+/Mesenchymal Stem Cell (MSC) injections into the ischemic tissue CLI mouse model improves function. Thus, we sought to determine mechanism action E-selectin+/MSC’s pro-angiogenic properties. Methods MSC were extracted from donor mice bone marrow subsequently engineered via viral transduction E-selectin-ires-GFP/AAV GFP/AAV (control) create E-selectin-GFP+/MSC vs GFP+/MSC. Intramuscular E-selectin-GFP+/MSC, GFP+/MSC, or PBS performed hindlimb ischemia. Laser doppler imaging (LDI), confocal laser microscopy, treadmill exhaustion test utilized neovascularization RNA extraction (E-selectin-GFP+/MSC GFP+/MSC) tissues treated GFP+/MSC was performed, followed by RT2 Profiler PCR Array analysis 84 genes involved angiogenesis. served as control. Student’s t-test ANOVA compare means significance set at P < 0.05. Results Compared PBS, treatment increased leg LDI reperfusion (54% vs. 39% 22%, 0.001), distance traversed (162 m 111 110 m, 0.01) footpad vessel density (23% 14% 14%, 0.01). demonstrated gene upregulation occurred 7 (Csf3, Cxcl2, Cxcl5, Serpine1, F2, Lep, Tbx1, Table I.) while tumour necrosis factor (TNF) found be downregulated, when compared tissues. Of these upregulated genes, CXCl2, Leptin T-box1 (Table are likely produced cellular expression profiles also revealed 2-fold more factors Validation functions in-vivo under investigation. Conclusion cell therapy using murine CLI, confers both augmented postnatal The pro-repair effects mediated panel chemokines/cytokines down-regulation TNF E-selectin-GFP+/MSC.
منابع مشابه
Stem Cell Therapy in Hypoxic Ischemic Encephalopathy
Introduction there are one million deaths from asphyxia in newborn annually. Management of this newborn is only supportive. Autologuse stem cell therapy may reduce mortality and long term morbidity. Outcome of asphyxiated newborn is related to damage CNS cells. Stem cells prevent Apoptosis and induce repairmen of injured neurons. Methods in a review study all article related to three keyword...
متن کاملEnhanced revascularization of the ischemic limb by angiogenic therapy.
BACKGROUND This study tests the efficacy of an angiogenic growth factor, endothelial cell growth factor, in a rabbit model of persistent hindlimb ischemia. METHODS AND RESULTS Ischemia was induced in the left hindlimb of 22 New Zealand White rabbits by ligation of the distal external iliac artery and complete excision of the common and superficial femoral arteries. Two groups of animals were ...
متن کاملstem cell therapy in hypoxic ischemic encephalopathy
introduction there are one million deaths from asphyxia in newborn annually. management of this newborn is only supportive. autologuse stem cell therapy may reduce mortality and long term morbidity. outcome of asphyxiated newborn is related to damage cns cells. stem cells prevent apoptosis and induce repairmen of injured neurons. methods in a review study all article related to three keywords o...
متن کاملAngiogenic cell therapy for severe ischemic diseases.
Cell therapies for severe ischemic diseases such as limb ischemia, acute myocardial infarction, and cerebral ischemia have been developed through in vitro and in vivo animal and clinical studies. Active cells for angiogenic cell therapy are believed endothelial progenitor cells (EPCs). EPCs have been extensively investigated to clarify their origin and biology. Many sources of EPCs have been pr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Surgery
سال: 2021
ISSN: ['1365-2168', '0007-1323']
DOI: https://doi.org/10.1093/bjs/znab282.011